Protara Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
TARA Nasdaq 8731 https://protaratx.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Protara Therapeutics Inc

Protara Therapeutics Announces Dosing of First Patients in Phase 1b ADVANCED-1EXP Trial of TARA-002 in NMIBC Patients with Carcinoma in Situ - May 15th, 2023 12:00 pm
Protara Therapeutics Announces First Quarter 2023 Financial Results and Business Update - May 4th, 2023 12:00 pm
Protara Therapeutics Receives Regulatory Clearance from FDA to Commence Phase 2 STARBORN-1 Trial of TARA-002 in Pediatric Patients with Lymphatic Malformations - May 2nd, 2023 12:00 pm
Protara Therapeutics Announces Positive Preliminary Data from ADVANCED-1 Phase 1a Dose Escalation Trial of TARA-002 in NMIBC Supporting Advancement into Phase 2 Clinical Development - Apr 28th, 2023 12:00 pm
Protara Therapeutics Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update - Mar 8th, 2023 1:00 pm
Protara Therapeutics to Participate in Upcoming Investor Conferences - Mar 1st, 2023 1:00 pm
Protara Therapeutics to Present at the Guggenheim Healthcare Talks Oncology Day - Feb 2nd, 2023 1:00 pm
Protara Therapeutics Announces Appointment of Patrick Fabbio as Chief Financial Officer - Jan 30th, 2023 1:00 pm
Protara Therapeutics Announces Trials in Progress Poster Presentation for the ADVANCED-1 Trial in NMIBC at the 23rd Annual Meeting of the Society of Urologic Oncology - Dec 1st, 2022 1:00 pm
Protara Therapeutics Announces Third Quarter 2022 Financial Results and Business Overview - Nov 3rd, 2022 12:00 pm
Is Protara Therapeutics (NASDAQ:TARA) In A Good Position To Invest In Growth? - Oct 24th, 2022 12:35 pm
Protara Therapeutics to Present at H.C. Wainwright 24th Annual Global Investment Conference - Sep 6th, 2022 12:00 pm
Protara Therapeutics Announces Second Quarter 2022 Financial Results and Business Overview - Aug 9th, 2022 12:00 pm
Protara Therapeutics Announces Departure of Chief Financial Officer - Jun 21st, 2022 12:00 pm